C WorldWide Group’s Abiomed Inc ABMD Stock Holding History

C WorldWide Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-60,000	Closed	-$3.94M	–	138
2015 Q2	$3.94M	Sell	60,000 -24,888	-29%	-$1.65M	0.06%	66
2015 Q1	$6.08M	Sell	84,888 -20,000	-19%	-$1.09M	0.09%	51
2014 Q4	$3.99M	Sell	104,888 -65,112	-38%	-$2.05M	0.06%	53
2014 Q3	$4.25M	Buy	+170,000	New	+$4.31M	0.06%	55

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C WorldWide Group's ABMD Position: Q3 2015 in Review

C WorldWide Group sold out of Abiomed Inc (ABMD) in Q3 2015, closing a stake of 60,000 shares — an estimated $3.94M sold.

C WorldWide Group first reported a position in ABMD in Q3 2014 and held it in 4 quarters. The position peaked at $6.08M in Q1 2015. 243 funds tracked by Wall St. Rank hold ABMD as of Q3 2015.

C WorldWide Group reported no remaining Abiomed Inc position as of Q3 2015 after selling out during the quarter.
C WorldWide Group sold 60,000 Abiomed Inc shares in Q3 2015, an estimated $3.94M.
C WorldWide Group first reported a position in Abiomed Inc in Q3 2014 and held it in 4 quarters.
C WorldWide Group's Abiomed Inc position peaked at $6.08M in Q1 2015.
243 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2015.

Based on C WorldWide Group's 13F filing for Q3 2015, filed 12 Nov 2015.